<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139636">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02020382</url>
  </required_header>
  <id_info>
    <org_study_id>P120903</org_study_id>
    <secondary_id>2013-A00310-45</secondary_id>
    <nct_id>NCT02020382</nct_id>
  </id_info>
  <brief_title>Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases</brief_title>
  <acronym>MicroMICI</acronym>
  <official_title>Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the diagnostic value of microRNAs in IBD colon
      (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and
      non-IBD colitis)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RATIONAL Inflammatory Bowel Disease (IBD) affects more than 200,000 people in France and 1.5
      million in Europe. Difficulties in the management of IBD are related to the need for
      invasive tests for the diagnosis of IBD (endoscopy), partly explaining the delay in
      diagnosis, and the inability to distinguish early colonic Crohn's disease of ulcerative
      colitis (UC) in 10-30% of cases.

      Recently, we identified real-time polymerase chain reaction (PCR), from healthy colonic
      mucosa of IBD patients, a molecular signature of IBD involving 10 microRNA (miRNA) Common
      (miR26a, miR29a, miR29b, miR126 * miR15a, miR127-3p, miR324 -3p, miR30c, miR185, miR196a)
      and 15 colic chronic disease (MC) and ulcerative colitis (RCH) discriminating microRNA
      (miR-142-3p, miR-142-5p, miR-146a, miR-146b-5p, miR150, miR-181d, miR-182, miR199a -3p,
      miR199a-5p, miR199b-5p, miR-203, miR223, miR-299-5p, miR320a, miR-328).

      TYPE OF STUDY : multicenter diagnostic evaluation Study

      MAIN PURPOSE OF THE STUDY : To evaluate the diagnostic value of microRNA in colonic IBD
      (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and
      non-IBD colitis)

      SECONDARY OBJECTIVES :

        -  assess the ability of microRNA to discriminate a colic chronic disease (MC)  of
           ulcerative colitis (RCH) in adults

        -  evaluate the diagnostic value of microRNA in inflammatory colitis child

        -  explore the possibility of measuring miRNA of interest in the stool

      PRODUCTS OF THE STUDY diagnostic kit of IBD in quantitative polymerase chain reaction (qPCR)

      NUMBER OF PATIENTS : 6 groups of 50 patients each will be included

        -  Group 1: Crohn adult colic

        -  Group 2: ulcerative colitis (RCH) adults

        -  Group 3: Witnesses healthy adults

        -  Group 4: Witnesses adults with non-IBD inflammation

        -  Group 5: Children with colitis

        -  Group 6 : Witnesses healthy children

      INCLUSION LENGTH 30 months

      DURATION OF THE STUDY 30 months
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Evaluate the diagnostic value of microRNAs in qPCR,in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the diagnostic value of microRNAs in qPCR, suitable for routine use, initially testing the expression of 25 miRNAs from endoscopic biopsies in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Evaluate the ability of miRNAs to discriminate a MC colic of UC in adults</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the diagnostic value of microRNAs in inflammatory colitis child</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Study the possibility of measuring miRNA of interest in feces and saliva</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Ulcerative Colitis,</condition>
  <condition>Crohn's Disease,</condition>
  <condition>Healthy</condition>
  <condition>Non-IBD Colitis</condition>
  <arm_group>
    <arm_group_label>Crohn adult colic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RCH adults</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Witnesses healthy adults</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Witnesses adults with non-IBD inflammation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children with colitis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Witnesses healthy children</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>qPCR diagnostic KIT of microRNAS</intervention_name>
    <description>testing qPCR diagnostic KIT of microRNAS from colonic biopsies</description>
    <arm_group_label>Crohn adult colic</arm_group_label>
    <arm_group_label>RCH adults</arm_group_label>
    <arm_group_label>Witnesses healthy adults</arm_group_label>
    <arm_group_label>Witnesses adults with non-IBD inflammation</arm_group_label>
    <arm_group_label>Children with colitis</arm_group_label>
    <arm_group_label>Witnesses healthy children</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :

          -  Target Population : Patients (children and adults), man or woman, suffering from
             Crohn's disease with colonic involvement or ulcerative colitis according to the
             criteria of the European consensus (ECCO 2010)

          -  Control population: healthy subjects and any non-Crohn's colitis or ulcerative
             colitis

          -  Having a colonoscopy examination indication,

          -  Who signed the consent form (for adults and signed parental consent obtained for
             patients minors)

        Exclusion Criteria:

          -  No health insurance ,

          -  mental disability,

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Treton, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Treton, MD, PhD</last_name>
    <phone>01 40 87 56 57</phone>
    <email>xtreton@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>H么pital BEAUJON</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Treton, MD, PhD</last_name>
      <phone>01 40 87 56 57</phone>
      <email>xtreton@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Xavier Treton, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 29, 2013</lastchanged_date>
  <firstreceived_date>December 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microRNAs</keyword>
  <keyword>IBD</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>Ulcerative colitis</keyword>
  <keyword>colonic polyps screening</keyword>
  <keyword>controls</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
